<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Russian Journal of Allergy</journal-id><journal-title-group><journal-title xml:lang="en">Russian Journal of Allergy</journal-title><trans-title-group xml:lang="ru"><trans-title>Российский Аллергологический Журнал</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1810-8830</issn><issn publication-format="electronic">2686-682X</issn><publisher><publisher-name xml:lang="en">Publishing House ABV Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">806</article-id><article-id pub-id-type="doi">10.36691/RJA806</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Articles</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Статьи</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">PHARMACOLOGICAL SUPERVISION: THE EUROPEAN EXPERIENCE</article-title><trans-title-group xml:lang="ru"><trans-title>ФАРМАКОНАДЗОР: ЕВРОПЕЙСКИЙ ОПЫТ</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Gratsianskaya</surname><given-names>Anna Nikolaevna</given-names></name><name xml:lang="ru"><surname>Грацианская</surname><given-names>Анна Николаевна</given-names></name></name-alternatives><bio xml:lang="ru"><p>Российский государственный медицинский университет им. Н.И. Пирогова (ГОУ ВПО РГМУРосздрава)</p></bio><email>lusslv@yandex.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Gratsianskaya</surname><given-names>A N</given-names></name><bio xml:lang="en"><p>THE Russian State Medical University</p></bio><xref ref-type="aff" rid="aff2"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en"></institution></aff><aff><institution xml:lang="ru">Российский государственный медицинский университет им. Н.И. Пирогова (ГОУ ВПО РГМУРосздрава)</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">THE Russian State Medical University</institution></aff><aff><institution xml:lang="ru"></institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2011-06-15" publication-format="electronic"><day>15</day><month>06</month><year>2011</year></pub-date><volume>8</volume><issue>3</issue><issue-title xml:lang="en">NO3 (2011)</issue-title><issue-title xml:lang="ru">№3 (2011)</issue-title><fpage>65</fpage><lpage>67</lpage><history><date date-type="received" iso-8601-date="2020-03-10"><day>10</day><month>03</month><year>2020</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2011, Pharmarus Print Media</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2011, Фармарус Принт Медиа</copyright-statement><copyright-year>2011</copyright-year><copyright-holder xml:lang="en">Pharmarus Print Media</copyright-holder><copyright-holder xml:lang="ru">Фармарус Принт Медиа</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/" start_date="2013-09-15"/></permissions><self-uri xlink:href="https://rusalljournal.ru/raj/article/view/806">https://rusalljournal.ru/raj/article/view/806</self-uri><abstract xml:lang="en"><p/></abstract><trans-abstract xml:lang="ru"><p/></trans-abstract><kwd-group xml:lang="en"><kwd>medicines</kwd><kwd>drug safety</kwd><kwd>pharmacological supervision</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>лекарственные препараты</kwd><kwd>безопасность лекарств</kwd><kwd>фармаконадзор</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>WHO Policy Perspectives on Medicines - Pharmacovigilance: ensuring the safe use of medicines http://whqlibdoc.who. int/hq/2004/WHO_EDM_2004.8.pdf.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>http://teratology.org.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>http://www.who.int.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Shakir SA.W. PEM in the UK. In: Mann R.D., Andrews E., editors. Pharmacovigilance. Chichester, UK: John Wiley &amp; Sons Ltd. 2002.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Volume IX of the rules governing Medicinal Products for Human and Veterinary Use in the EU. Version December 2001 [online]. Available from URL: http://www.pharmacos.eudra.org/.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Mosley J.N.S. Risk Management. A European Regulatory Perspective. Drug Safety. 2004, v. 27 (8), p. 499-508.</mixed-citation></ref></ref-list></back></article>
